Thermo Fisher Scientific Inc (NYSE:TMO) Stake Maintained by North American Management Corp

North American Management Corp maintained its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) during the second quarter, Holdings Channel reports. The fund owned 8,721 shares of the medical research company’s stock at the end of the second quarter. North American Management Corp’s holdings in Thermo Fisher Scientific were worth $1,522,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the company. Toronto Dominion Bank boosted its stake in shares of Thermo Fisher Scientific by 53.5% in the first quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock valued at $16,450,000 after buying an additional 37,307 shares during the period. Chevy Chase Trust Holdings Inc. boosted its stake in shares of Thermo Fisher Scientific by 1.8% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 338,114 shares of the medical research company’s stock valued at $51,935,000 after buying an additional 5,944 shares during the period. Cigna Investments Inc. New acquired a new stake in shares of Thermo Fisher Scientific during the fourth quarter valued at approximately $2,051,000. Whalerock Point Partners LLC boosted its stake in shares of Thermo Fisher Scientific by 21.6% in the fourth quarter. Whalerock Point Partners LLC now owns 2,815 shares of the medical research company’s stock valued at $398,000 after buying an additional 500 shares during the period. Finally, Dodge & Cox acquired a new stake in shares of Thermo Fisher Scientific during the fourth quarter valued at approximately $7,055,000. 86.93% of the stock is currently owned by hedge funds and other institutional investors.

Thermo Fisher Scientific Inc (NYSE:TMO) traded down 0.09% on Monday, hitting $180.79. 1,297,250 shares of the stock traded hands. The firm has a market capitalization of $70.73 billion, a PE ratio of 32.98 and a beta of 1.06. The stock has a 50 day moving average of $173.88 and a 200 day moving average of $158.53. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $182.40.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, April 26th. The medical research company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.02 by $0.06. Thermo Fisher Scientific had a net margin of 11.58% and a return on equity of 15.73%. The company had revenue of $4.77 billion for the quarter, compared to analyst estimates of $4.68 billion. During the same period last year, the firm earned $1.80 earnings per share. The firm’s revenue was up 10.9% on a year-over-year basis. Equities research analysts anticipate that Thermo Fisher Scientific Inc will post $9.23 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is currently 10.95%.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/2723521/thermo-fisher-scientific-inc-nysetmo-stake-maintained-by-north-american-management-corp.html.

Several equities research analysts have commented on TMO shares. Cantor Fitzgerald started coverage on shares of Thermo Fisher Scientific in a research report on Thursday, May 18th. They set an “overweight” rating and a $194.00 price target on the stock. Barclays PLC set a $175.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Wednesday, April 26th. Cowen and Company reissued an “outperform” rating and set a $185.00 price target (up from $175.00) on shares of Thermo Fisher Scientific in a research report on Saturday, April 29th. Citigroup Inc. reissued a “buy” rating and set a $201.00 price target (up from $182.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 10th. Finally, BidaskClub raised shares of Thermo Fisher Scientific from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 11th. Two equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and an average target price of $186.71.

In related news, CEO Marc N. Casper sold 20,000 shares of the firm’s stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the transaction, the chief executive officer now directly owns 269,279 shares of the company’s stock, valued at $46,528,718.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of the firm’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $176.26, for a total transaction of $440,650.00. Following the transaction, the chief financial officer now directly owns 37,790 shares in the company, valued at $6,660,865.40. The disclosure for this sale can be found here. Insiders have sold 28,720 shares of company stock worth $4,960,764 over the last three months. 0.49% of the stock is owned by insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2017 Ticker Report. Google+.